Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union-Reference-Cited by-同舟云学术

Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union

Published:2023-07 Issue: Volume:642 Page:123193
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Manellari Sara,Musazzi Umberto M.^ORCID,Rocco Paolo,Minghetti Paola

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. European Medicines Agency (EMA), 2005a. Aptivus®: EPAR – Scientific Discussion. Available on the website: https://www.ema.europa.eu/en/documents/scientific-discussion/aptivus-epar-scientific-discussion_en.pdf. Last access: 30/11/2022.

2. European Medicines Agency (EMA), 2005b. Zevalin®: EPAR – Scientific Discussion. Available on the website: https://www.ema.europa.eu/en/documents/scientific-discussion/zevalin-epar-scientific-discussion_en.pdf. Last access: 30/11/2022.

3. European Medicines Agency (EMA), 2011a. Caprelsa®: EPAR – Public Assessment report. Available on the website: https://www.ema.europa.eu/en/documents/assessment-report/caprelsa-epar-public-assessment-report_en.pdf. Last access: 30/11/2022.

4. European Medicines Agency (EMA), 2011b. Public statement on Onsenal®: Withdrawal of the marketing authorisation in the European Union. Available on the website: https://www.ema.europa.eu/en/documents/public-statement/public-statement-onsenal-celecoxib-withdrawal-marketing-authorisation-european-union_en.pdf. Last access: 30/11/2022.

5. European Medicines Agency (EMA), 2012a. Public statement on Rilonacept Regeneron®: Withdrawal of the marketing authorisation in the European Union. Available on the website: https://www.ema.europa.eu/en/documents/public-statement/public-statement-rilonacept-regeneron-withdrawal-marketing-authorisation-european-union_en.pdf. Last access: 30/11/2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Statistics in Drug Development and Regulatory Approval;Advances in Bioinformatics and Biomedical Engineering;2024-07-18

2. Feeding Next‐Generation Nanomedicines to Europe: Regulatory and Quality Challenges;Advanced Healthcare Materials;2023-09-17